CHINA China to reward health fraud informants

CHINA

China to reward health fraud informants

Xinhua

18:46, December 17, 2018

VCG111177426708.jpg

(Photo: VCG)

BEIJING, Dec. 17 (Xinhua) -- China's healthcare authorities will financially reward whistleblowers of healthcare scams as part of the ongoing fight against fraud, the China Daily reported Monday.

Informants could receive 1 percent of the amount involved in the fraud after it is proved, if the case was previously unknown to authorities, the newspaper cited a circular released by the National Healthcare Security Administration and the Ministry of Finance.

Rewards should not exceed 100,000 yuan (around 14,500 U.S. dollars), according to the circular.

The public can report fraudulent practices by operators of healthcare insurance funds, medical institutions and pharmacies and their employees, as well as by individual insurance subscribers, it said.

Fraudulent practices include fabricating medical services and documents, providing fake invoices to subscribers, faking of medical service invoices by subscribers, lending a healthcare security card to others or receiving medical services with another person's card to profit from the fund.

Whistleblowers can use their names or make anonymous reports, but they must confirm their identity before they can collect any reward, the circular said.

The move is the latest effort in a nationwide campaign launched in September to fight insurance fraud.

More than 95 percent of the population in China are covered by basic healthcare insurance programs, which are heavily subsidized by the government.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue